Skip to main content

News

Population Health Learning Network
By Lisa Rapaport(Reuters Health) - A growing number of Americans find it too expensive to see doctors even though more people have health insurance, a U.S. study suggests.
Population Health Learning Network
By Lisa Rapaport(Reuters Health) - Screening black men for diabetes in barbershops may help identify people who don't realize they have the disease, a new study suggests.
Pharmacy Learning Network
“Opioid use should be minimized in those with cirrhosis and, when required, limited to short duration,” researchers concluded.
Pharmacy Learning Network
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices have updated guidance regarding the use of the tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine.
First Report Managed Care
Results from an analysis presented at the 2019 ASH Annual Meeting reveal significant risk factors for worse treatment response after CD-19 chimeric antigen receptor (CAR) T-cell therapy in relapsed/refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL).
First Report Managed Care
Findings from a retrospective study being presented at the 2019 ASH Annual Meeting support the use of bevacizumab to treat chronic bleeding and anemia in patients with hereditary hemorrhagic telangiectasia (HHT).
First Report Managed Care
Treatment of iron deficiency with low molecular weight iron dextran (LMWID) or ferumoxytol was well-tolerated and led to minimal adverse events (AEs), study findings have shown.
First Report Managed Care
According to data presented at the 2019 ASH Annual Meeting, patients with iron deficiency anemia (IDA) should be monitored for serum phosphate after being treated with ferric carboxymaltose.
First Report Managed Care
Findings being presented at the 2019 ASH Annual Meeting demonstrate that vosaroxin and infusional cytarabine is a safe treatment regimen for newly diagnosed patients with acute myeloid leukemia (AML).
First Report Managed Care
The addition of aspirin to direct oral anticoagulants (DOACs) in patients with venous thromboembolism (VTE) or nonvalvular atrial fibrillation (NVAF) resulted in more bleeding events without significant improvement in the incidence of thrombosis, according to a study presented at the 2019 ASH…
Back to Top